InventionMed S.A. (WSE:INM)
Poland flag Poland · Delayed Price · Currency is PLN
0.1015
-0.0020 (-1.93%)
At close: Jul 24, 2026

InventionMed Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013
Period EndingDec '25 Dec '25 Dec '24 Dec '14 Dec '13
Revenue
3.963.960.820.270.38
Revenue Growth
-381.78%209.81%-30.40%-
Gross Profit
3.453.450.230.230.32
Operating Income
0.270.27-2.47-0.12-0.26
Net Income
-1.3-1.3-46.911.47
Earnings Per Share
-0.06-0.06-0.190.330.08
EPS Growth
---303.03%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2014FY 2013
Period EndingMar '26 Dec '25 Dec '24 Dec '14 Dec '13
Cash & Investments
0.050.110.0113.544.04
Total Debt
24.7724.3621.480.630.29
Net Cash (Debt)
-24.72-24.25-21.4812.913.74
Net Cash Growth
---244.71%-
Net Cash Per Share
-1.19-1.17-1.030.620.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013
Period EndingDec '25 Dec '25 Dec '24 Dec '14 Dec '13
Operating Cash Flow
-0.5-0.50.83-0.46-0.02
Capital Expenditures
0.580.580.140.420.07
Free Cash Flow
0.080.080.97-0.030.05
Free Cash Flow Growth
--91.33%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013
Period EndingDec '25 Dec '25 Dec '24 Dec '14 Dec '13
Gross Margin
87.11%87.11%28.53%86.40%84.52%
Operating Margin
6.77%6.77%-300.56%-45.87%-67.98%
Pretax Margin
-32.82%-32.82%-487.09%3197.33%514.20%
Profit Margin
-32.82%-32.82%-487.08%3186.59%514.20%
FCF Margin
2.11%2.11%117.51%-12.26%13.56%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2014FY 2013
Period EndingJul '26 Dec '25 Dec '24 Dec '14 Dec '13
PE Ratio
488.35--1.69-
P/FCF Ratio
-26.344.72--
PS Ratio
5.500.565.5444.07-